Refametinib R enantiomer

CAS No. 923032-38-6

Refametinib R enantiomer( BAY 869766 R enantiomer | RDEA119 R enantiomer | RDEA-119 R enantiomer | BAY 86-9766 R enantiomer )

Catalog No. M16610 CAS No. 923032-38-6

The R enantiomer of Refametinib, a potent, non–ATP-competitive, highly selective, allosteric inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 189 In Stock
10MG 279 In Stock
25MG 527 In Stock
50MG 702 In Stock
100MG 981 In Stock
500MG 1962 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Refametinib R enantiomer
  • Note
    Research use only, not for human use.
  • Brief Description
    The R enantiomer of Refametinib, a potent, non–ATP-competitive, highly selective, allosteric inhibitor.
  • Description
    The R enantiomer of Refametinib, a potent, non–ATP-competitive, highly selective, allosteric inhibitor of MEK1/2 with IC50 of 19/47 nM respectively.
  • In Vitro
    Refametinib R enantiomer is the R enantiomer of Refametinib . Refametinib R enantiomer is an inhibitor of MEK and is useful in treatment of cancer and other hyperproliferative diseases.
  • In Vivo
    ——
  • Synonyms
    BAY 869766 R enantiomer | RDEA119 R enantiomer | RDEA-119 R enantiomer | BAY 86-9766 R enantiomer
  • Pathway
    MAPK/ERK Signaling
  • Target
    MEK
  • Recptor
    MEK
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    923032-38-6
  • Formula Weight
    572.3372
  • Molecular Formula
    C19H20F3IN2O5S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO
  • SMILES
    COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)CC(CO)O)NC3=C(C=C(C=C3)I)F)F)F
  • Chemical Name
    Cyclopropanesulfonamide, N-[3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl]-1-[(2R)-2,3-dihydroxypropyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Iverson C, et al. Cancer Res. 2009 Sep 1;69(17):6839-47. 2. Chang Q, et al. BMC Cancer. 2010 Sep 28;10:515. 3. Schmieder R, et al. Neoplasia. 2013 Oct;15(10):1161-71.
molnova catalog
related products
  • MEK-IN-4

    MEK-IN-4 is a MEK inhibitor utilized in the study of inflammatory diseases and cancer.

  • AKS1-IN-19

    A novel potent, selective and orally active ASK1 (MAP3K5) inhibitor with pIC50 of 8.3.

  • NQDI-1

    NQDI-1 is a potent and selective inhibitor of apoptosis signal-regulating kinase 1 (ASK1) with Ki of 500 nM.